Brenntag/€BNR
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Brenntag
Brenntag SE is a global leader in chemical distribution, providing comprehensive solutions in the chemical sector to a diverse range of industries, including pharmaceuticals, personal care, and coatings. Founded in 1874 and headquartered in Essen, Germany, the company operates an extensive network delivering both industrial and specialty chemicals worldwide. Brenntag is listed on the Frankfurt Stock Exchange under the ticker symbol 'BNR', reflecting its significant role in the global market as a connector between chemical manufacturers and an array of industry consumers.
Ticker
€BNR
Sector
Primary listing
XETRA
Employees
17,502
Headquarters
Website
Brenntag Metrics
BasicAdvanced
€7.3B
17.29
€2.93
0.73
€2.10
4.15%
Price and volume
Market cap
€7.3B
Beta
0.73
52-week high
€68.72
52-week low
€50.20
Average daily volume
7.3K
Dividend rate
€2.10
Financial strength
Current ratio
1.503
Quick ratio
1.031
Long term debt to equity
61.208
Total debt to equity
81.218
Dividend payout ratio (TTM)
71.68%
Interest coverage (TTM)
4.66%
Profitability
EBITDA (TTM)
1,086.6
Gross margin (TTM)
25.04%
Net profit margin (TTM)
2.64%
Operating margin (TTM)
4.61%
Effective tax rate (TTM)
28.36%
Revenue per employee (TTM)
€910,000
Management effectiveness
Return on assets (TTM)
4.16%
Return on equity (TTM)
9.86%
Valuation
Price to earnings (TTM)
17.286
Price to revenue (TTM)
0.457
Price to book
1.74
Price to tangible book (TTM)
13.67
Price to free cash flow (TTM)
12.476
Free cash flow yield (TTM)
8.02%
Free cash flow per share (TTM)
4.057
Dividend yield (TTM)
4.15%
Forward dividend yield
4.15%
Growth
Revenue change (TTM)
-1.30%
Earnings per share change (TTM)
-28.62%
3-year revenue growth (CAGR)
-2.71%
10-year revenue growth (CAGR)
4.44%
3-year earnings per share growth (CAGR)
-15.51%
10-year earnings per share growth (CAGR)
1.60%
3-year dividend per share growth (CAGR)
13.14%
10-year dividend per share growth (CAGR)
8.84%
What the Analysts think about Brenntag
Analyst ratings (Buy, Hold, Sell) for Brenntag stock.
Bulls say / Bears say
Brenntag’s cost containment initiatives delivered EUR 30 million in savings in Q2 2025, supporting the company’s aim to achieve EUR 300 million in annual cost reductions by 2027 (Brenntag)
Acquisitions of mcePharma in the Czech Republic and GSZ Kaiserslautern in Germany in Q2 2025 have strengthened Brenntag’s Specialties and Essentials segments, broadening its reach in the high-growth biopharma and hazardous substance storage sectors (Brenntag)
Brenntag proposed a stable dividend of EUR 2.10 per share for 2024, marking the 14th consecutive annual increase, backed by resilient free cash flow and a strong balance sheet (Brenntag)
In Q2 2025, Brenntag’s sales dropped 7.3% year-on-year to EUR 3,869.4 million, and operating EBITA fell 17.1% to EUR 246.4 million, reflecting substantial demand weakness and margin pressure (Brenntag)
The company reduced its full-year 2025 operating EBITA guidance to EUR 950–1,050 million, down from the previous range of EUR 1,100–1,300 million, indicating a worsening earnings outlook in the face of continued market challenges (Brenntag)
Adverse EUR/USD exchange rate movements further affected Brenntag’s profitability in Q2 2025, with currency headwinds expected to continue into the second half of the year (Brenntag)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Brenntag Financial Performance
Revenues and expenses
Brenntag Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Brenntag stock?
Brenntag (BNR) has a market cap of €7.3B as of September 11, 2025.
What is the P/E ratio for Brenntag stock?
The price to earnings (P/E) ratio for Brenntag (BNR) stock is 17.29 as of September 11, 2025.
Does Brenntag stock pay dividends?
Yes, the Brenntag (BNR) stock pays dividends to shareholders. As of September 11, 2025, the dividend rate is €2.1 and the yield is 4.15%. Brenntag has a payout ratio of 71.68% on a trailing twelve-month basis.
When is the next Brenntag dividend payment date?
The next Brenntag (BNR) dividend payment date is unconfirmed.
What is the beta indicator for Brenntag?
Brenntag (BNR) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.